GlaxoSmithKline plc on Wednesday reported a 34 percent increase in profit for the third quarter from last year, reflecting strong demand for its new HIV and respiratory products as well as its meningitis vaccines. Looking ahead, the company affirmed its earnings outlook for fiscal 2017.
from RTT - Earnings http://ift.tt/2lfnlBS
via IFTTT
No comments:
Post a Comment